Enterprise Therapeutics is a biopharmaceutical company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.

Company Name

Enterprise Therapeutics

Location

Brighton, U.K.

Investment Stage

Enterprise was acquired by Roche in 2020